Search results
The Forever Dividend Portfolio: 3 A-Rated Stocks to Buy and Hold
InvestorPlace· 18 hours agoDividend Stocks are crucial for any portfolio, because investors can gain substantial dividend...
Why Is Mustang Bio (MBIO) Stock Up 58% Today?
InvestorPlace· 17 hours agoMustang Bio (NASDAQ:MBIO) stock is taking off on Wednesday alongside heavy pre-market trading of the clinical-stage biopharmaceutical company’s shares....
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst | The Motley Fool
The Motley Fool· 3 days agoGinkgo Bioworks (DNA -4.90%) stock has dropped more than 10% since its latest quarterly report...
From Hype to Bust: The Downfall of Teladoc, Bark and Nike Stocks
InvestorPlace via Yahoo Finance· 6 days agoFinding stocks to sell in 2024 is straightforward, but actually executing those trades is another...
Why Is AmpliTech (AMPG) Stock Down 34% Today?
InvestorPlace· 6 days agoAmpliTech (NASDAQ:AMPG) stock is falling on Friday after the company provided a late quarterly filing notice to the Securities and Exchange Commission...
Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 78% Today?
InvestorPlace· 2 days agoBiodexa Pharmaceuticals (NASDAQ:BDRX) stock is rocketing higher on Tuesday alongside heavy...
Why Is GT Biopharma (GTBP) Stock Up 143% Today?
InvestorPlace· 3 days agoGT Biopharma (NASDAQ:GTBP) stock is soaring higher on Monday alongside heavy pre-market trading of the clinical-stage biopharmaceutical company’s shares....
Vivek Ramaswamy Is Betting Big on BuzzFeed (BZFD) Stock
InvestorPlace· 13 hours agoIndeed, the former Republican candidate has acquired an activist stake in BuzzFeed (NASDAQ:BZFD) and BZFD stock. Originally an entertainment company that published online ...
Why Is Greenwave Technology Solutions (GWAV) Stock Down 60% Today?
InvestorPlace· 2 days agoGreenwave Technology Solutions (NASDAQ:GWAV) stock is falling on Tuesday after the metal recycling...
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
Motley Fool via Yahoo Finance· 3 days agoBTIG analyst Mark Massaro downgraded Ginkgo stock to sell, and lowered his price on this biotech ...
